| EMA number | EMEA/H/C/000396 |
| ATC code | B01AD10 |
| Authorisation | 22 August 2002 |
| Withdrawn | 28 November 2011 |
| Revision | 13 |
Xigris is indicated for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. The use of Xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure (for further information see section 5.1).